User profiles for C. Zerna

Charlotte Zerna

University of Calgary
Verified email at ucalgary.ca
Cited by 3800

Defining optimal brain health in adults: a presidential advisory from the American Heart Association/American Stroke Association

…, FD Testai, S van Gaal, K Yaffe, H Wasiak, C Zerna - Stroke, 2017 - Am Heart Assoc
Cognitive function is an important component of aging and predicts quality of life, functional
independence, and risk of institutionalization. Advances in our understanding of the role of …

Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke

C Zerna, G Thomalla, BCV Campbell, JH Rha, MD Hill - The Lancet, 2018 - thelancet.com
Even though stroke presents as a variety of clinical syndromes, neuroimaging is the most
important biomarker to help differentiate between stroke subtypes and assess treatment …

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised …

…, C Galloway, C Odier, C Deacon, C Zerna… - The Lancet, 2022 - thelancet.com
Background Intravenous thrombolysis with alteplase bolus followed by infusion is a global
standard of care for patients with acute ischaemic stroke. We aimed to determine whether …

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

…, RH Swartz, RA Shah, E Sauvageau, C Zerna… - The Lancet, 2020 - thelancet.com
Background Nerinetide, an eicosapeptide that interferes with post-synaptic density protein
95, is a neuroprotectant that is effective in preclinical stroke models of ischaemia-reperfusion. …

Therapeutic strategies and drug development for vascular cognitive impairment

…, LA Sposato, RH Swartz, C Zerna… - Journal of the …, 2017 - Am Heart Assoc
… Finally, VCI trials may be based on an expectation of preventing symptomatic VCI (Figure
1C). Many such trials define patient eligibility based on clinically defined cerebrovascular …

Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment

…, S Batool, CR McCreary, DB Hogan, Z Ismail, C Zerna… - Stroke, 2016 - Am Heart Assoc
Background and Purpose— Autopsy studies suggest that cerebral amyloid angiopathy (CAA)
is associated with cognitive impairment and risk for dementia. We analyzed …

Improving door-to-needle times for acute ischemic stroke: effect of rapid patient registration, moving directly to computed tomography, and giving alteplase at the …

…, MD Hill, RL Vilneff, E Bugbee, C Zerna… - … Quality and Outcomes, 2017 - Am Heart Assoc
Background— The effectiveness of specific systems changes to reduce DTN (door-to-needle)
time has not been fully evaluated. We analyzed the impact of 4 specific DTN time reduction …

Multiphase CT angiography increases detection of anterior circulation intracranial occlusion

AYX Yu, C Zerna, Z Assis, JK Holodinsky… - Neurology, 2016 - AAN Enterprises
C. Zerna contributed to the study concept and design, acquisition, analysis, and interpretation
of the data, and revising the manuscript. Z. Assis contributed to the study concept and …

[HTML][HTML] Association between influenza vaccination and risk of stroke in Alberta, Canada: a population-based study

JK Holodinsky, C Zerna, S Malo, LW Svenson… - The Lancet Public …, 2022 - thelancet.com
Background Respiratory infection can be an immediate precursor to stroke and myocardial
infarction. Influenza vaccination is associated with reduced risk of myocardial infarction and …

Outcomes after endovascular thrombectomy with or without alteplase in routine clinical practice

EE Smith, C Zerna, N Solomon, R Matsouaka… - JAMA …, 2022 - jamanetwork.com
Importance The effectiveness and safety of intravenous alteplase given before or concurrently
with endovascular thrombectomy (EVT) is uncertain. Randomized clinical trials suggest …